RESUMEN
An increasing amount of research has been conducted on immunoglobulin Y (IgY) because the use of IgY offers several advantages with respect to diagnostic testing, including its easy accessibility, low cost and translatability to large-scale production, in addition to the fact that it can be ethically produced. In a previous work, immunoglobulin was produced and purified from egg yolks (IgY) reactive to hepatitis A virus (HAV) antigens. In the present work, this anti-HAV-specific IgY was used in an indirect immunofluorescence assay to detect viral antigens in liver biopsies that were obtained from experimentally infected cynomolgus monkeys. Fields that were positive for HAV antigen were detected in liver sections using confocal microscopy. In conclusion, egg yolks from immunised hens may be a reliable source for antibody production, which can be employed for immunological studies.
Asunto(s)
Virus de la Hepatitis A/inmunología , Hepatitis A/diagnóstico , Inmunoglobulinas/análisis , Hígado/virología , Animales , Modelos Animales de Enfermedad , Técnica del Anticuerpo Fluorescente Indirecta , Hepatitis A/inmunología , Anticuerpos de Hepatitis A/inmunología , Antígenos de Hepatitis A/inmunología , Macaca fascicularis , Sensibilidad y EspecificidadRESUMEN
Producing specific antibodies in chickens is an attractive approach for diagnosis or therapeutic applications. Besides the high immunoglobulin Y (IgY) yield transferred to the egg yolk and its suitability for large-scale production, such an approach is more bioethical for animal maintenance. The IgY technology offers new possibilities for application in human and veterinary diagnostics and therapeutics, including strategies for treating severe intestinal diseases in children, particularly in emerging countries. Herein, we describe the production and purification of polyclonal antibodies against rotavirus group A (RVA) in immunised hens aiming at its application in prophylaxis and treatment of rotavirus-induced diarrhoea. For this purpose, we inoculated Rhodia laying chickens (Gallus gallus domesticus) with two or three doses of RVA combined with adjuvants or only adjuvants (control group). As the egg-laying period began, the yolk protein purification processes yielded a high concentration of specific IgY, the highest titre resulting from the group of hens that received three doses of the immunogen. The purified IgY blocked the functional activity of RVA in MA-104 cells, thus confirming the neutralisation ability. Therefore, anti-RVA IgY could be a promising candidate for pre- and post-exposure prevention or treatment of rotavirus-induced diarrhoea.
Asunto(s)
Yema de Huevo , Rotavirus , Animales , Anticuerpos , Pollos , Niño , Diarrea/prevención & control , Diarrea/veterinaria , Proteínas del Huevo , Femenino , Humanos , InmunoglobulinasRESUMEN
The unusual phenotype of CD3+ T lymphocyte expressing B220, a marker originally attributed to B lymphocytes, was first observed in the liver of Fas/Fas-L-deficient mice as a marker of apoptotic T lymphocytes. However, other CD3+B220+ T lymphocyte populations were later described in the periphery as functional cytotoxic or regulatory cells, for example. Then, in this work, we studied whether hepatic CD3+B220+ T lymphocytes could play a role in experimental Trypanosoma cruzi infection. In control and infected mice, we observed two subpopulations that could be discerned based on CD117 expression, which were conventional apoptotic CD3+B220+(CD117-) and thymus-independent CD3+B220+CD117+ T lymphocytes. Regardless of CD117 expression, most B220+ T lymphocytes were 7AAD+, confirming this molecule as a marker of dying T cells. However, after infection, we found that around 15% of the CD3+B220+CD117+ hepatic population became B220 and 7AAD negative, turned into CD90.2+, and upregulated the expression of CD44, CD49d, and CD11a, a phenotype consistent with activated T lymphocytes. Moreover, we observed that the hepatic CD3+B220+CD117+ population was rescued from death by previously activated peripheral T lymphocytes. Our results extend the comprehension of the hepatic CD3+B220+ T lymphocyte subpopulations and illustrate the complex interactions that occur in the liver.
RESUMEN
Group A rotaviruses (RVA) are one of the most common causes of severe acute gastroenteritis in infants worldwide. Rotaviruses spread from person to person, mainly by faecalâ»oral transmission. Almost all unvaccinated children may become infected with RVA in the first two years of life. The establishment of an experimental monkey model with RVA is important to evaluate new therapeutic approaches. In this study, we demonstrated viral shedding and viraemia in juvenileâ»adult Macaca fascicularis orally inoculated with Wa RVA prototype. Nine monkeys were inoculated orally: seven animals with human RVA and two control animals with saline solution. During the study, the monkeys were clinically monitored, and faeces and blood samples were tested for RVA infection. In general, the inoculated animals developed an oligosymptomatic infection pattern. The main clinical symptoms observed were diarrhoea in two monkeys for three days, associated with a reduction in plasmatic potassium content. Viral RNA was detected in seven faecal and five sera samples from inoculated animals, suggesting virus replication. Cynomolgus monkeys are susceptible hosts for human Wa RVA infection. When inoculated orally, they presented self-limited diarrhoea associated with presence of RVA infectious particles in faeces. Thus, cynomolgus monkeys may be useful as animal models to evaluate the efficacy of new antiviral approaches.
Asunto(s)
Infecciones por Rotavirus/virología , Rotavirus/fisiología , Animales , Modelos Animales de Enfermedad , Heces/virología , Humanos , Macaca fascicularis , ARN Viral , Rotavirus/clasificación , Infecciones por Rotavirus/sangre , Carga Viral , Replicación Viral , Esparcimiento de VirusRESUMEN
Epidemiological studies found that hepatitis E virus genotype 3 (HEV-3) infection was associated with chronic hepatitis and cirrhosis in immunocompromised patients. Our study aimed to investigate the relationship between the host immunosuppressive status and the occurrence of HEV-related chronic hepatitis. Here we describe a successful experimental study, using cynomolgus monkeys previously treated with tacrolimus, a potent calcineurin inhibitor immunosuppressant, and infected with a Brazilian HEV-3 strain isolated from naturally infected pigs. HEV infected monkeys were followed up during 160 days post infection (dpi) by clinical signs; virological, biochemical and haematological parameters; and liver histopathology. The tacrolimus blood levels were monitored throughout the experiment. Immunosuppression was confirmed by clinical and laboratorial findings, such as: moderate weight loss, alopecia, and herpes virus opportunistic infection. In this study, chronic HEV infection was characterized by the mild increase of liver enzymes serum levels; persistent RNA viremia and viral faecal shedding; and liver histopathology. Three out of four immunosuppressed monkeys showed recurrent HEV RNA detection in liver samples, evident hepatocellular ballooning degeneration, mild to severe macro and microvesicular steatosis (zone 1), scattered hepatocellular apoptosis, and lobular focal inflammation. At 69 dpi, liver biopsies of all infected monkeys revealed evident ballooning degeneration (zone 3), discrete hepatocellular apoptosis, and at most mild portal and intra-acinar focal inflammation. At 160 dpi, the three chronically HEV infected monkeys showed microscopic features (piecemeal necrosis) corresponding to chronic hepatitis in absence of fibrosis and cirrhosis in liver parenchyma. Within 4-months follow up, the tacrolimus-immunosuppressed cynomolgus monkeys infected with a Brazilian swine HEV-3 strain exhibited more severe hepatic lesions progressing to chronic hepatitis without liver fibrosis, similarly as shown in tacrolimus-immunosuppressed solid organ transplant (SOT) recipients. The cause-effect relationship between HEV infection and tacrolimus treatment was confirmed in this experiment.
Asunto(s)
Virus de la Hepatitis E/patogenicidad , Inmunosupresores/inmunología , Macaca fascicularis/inmunología , Macaca fascicularis/virología , Animales , Brasil , Femenino , Genotipo , Anticuerpos Antihepatitis/inmunología , Hepatitis E/inmunología , Hepatitis E/virología , Virus de la Hepatitis E/genética , Virus de la Hepatitis E/inmunología , Terapia de Inmunosupresión/métodos , Hígado/inmunología , Hígado/virología , Cirrosis Hepática/inmunología , Cirrosis Hepática/virología , Pruebas de Función Hepática/métodos , Masculino , ARN Viral/genética , Esparcimiento de Virus/inmunologíaRESUMEN
An increasing amount of research has been conducted on immunoglobulin Y (IgY) because the use of IgY offers several advantages with respect to diagnostic testing, including its easy accessibility, low cost and translatability to large-scale production, in addition to the fact that it can be ethically produced. In a previous work, immunoglobulin was produced and purified from egg yolks (IgY) reactive to hepatitis A virus (HAV) antigens. In the present work, this anti-HAV-specific IgY was used in an indirect immunofluorescence assay to detect viral antigens in liver biopsies that were obtained from experimentally infected cynomolgus monkeys. Fields that were positive for HAV antigen were detected in liver sections using confocal microscopy. In conclusion, egg yolks from immunised hens may be a reliable source for antibody production, which can be employed for immunological studies.
Asunto(s)
Animales , Virus de la Hepatitis A/inmunología , Hepatitis A/diagnóstico , Inmunoglobulinas/análisis , Hígado/virología , Modelos Animales de Enfermedad , Técnica del Anticuerpo Fluorescente Indirecta , Anticuerpos de Hepatitis A/inmunología , Antígenos de Hepatitis A/inmunología , Hepatitis A/inmunología , Macaca fascicularis , Sensibilidad y EspecificidadRESUMEN
O rotavírus é a causa mais frequente de gastroenterite aguda (GA) em crianças menores decinco anos de idade em todo o mundo, sendo responsável por até 200 mil mortes anualmente.Sua disseminação ocorre pelo contato pessoa-pessoa, principalmente pela via de transmissãofecal-oral. Embora haja vacinas disponíveis e em desenvolvimento para a rotavirose, medidasalternativas são necessárias como, por exemplo, nos casos de surto. Dessa forma, a utilizaçãode imunoglobulina Y (IgY) em imunoterapia passiva é justificável. A IgY é a imunoglobulinaque predomina na circulação das aves, sendo transferida por secreção ativa do sangue para agema dos ovos, a partir da qual a purificação é realizada para obtenção dos anticorposespecíficos de interesse. As vantagens apresentadas por esta metodologia incluem: fácilobtenção, baixo custo e capacidade de produção em larga escala de modo adequado a umpadrão bioético mais atual. É crescente sua aplicação em métodos de diagnóstico eimunoterapia passiva. Neste estudo, avaliamos a infectividade do rotavírus A (RVA) humanoem macacos cynomolgus (Macaca fascicularis) e a aplicação terapêutica da IgY específicaanti-rotavírus após desafio com RVA pela via oral. Os animais que receberam o tratamentoforam divididos em dois grupos: um recebeu IgY apenas pela via oral e outro pela via oral eintravenosa. Os animais foram acompanhados por cinco dias e foram avaliados sinais clínicos,carga viral sérica e fecal, hematologia e dosagem de eletrólitos séricos. Além disso, buscou-sedefinir o perfil de células do sistema imune no sangue periférico, assim como detecção decitocinas no soro dos animais, ensaios de imunofluorescência para detecção da proteína nãoestrutural do rotavírus e também das células do sistema imune em cortes congelados deintestino...
Rotavirus is the most common cause of acute gastroenteritis in children under five years oldworldwide, accounting for about 200,000 deaths per year. Its spread is due to person to personcontact, mainly through fecal-oral transmission. Although there are vaccines available forrotavirus, alternative measures are required, for example, in outbreaks. Thus, the use ofimmunoglobulin Y (IgY) in passive immunotherapy is justified. The IgY is the predominantimmunoglobulin in birds circulation, being transferred from the blood by active secretion intothe yolk of eggs from which the purification is performed to obtain the specific antibody ofinterest. The advantages presented by this methodology include: easy obtainment, low cost,and production capacity in large-scale, appropriate considering current bioethical guiderlines.IgY is increasing employed in methods of diagnosis and passive immunotherapy. This studyevaluated the infectivity of human rotavirus A (RVA) in cynomolgus monkeys (Macacafascicularis) and therapeutic function of IgY after challenge with RVA orally. The animalswere divided in two groups: one that received IgY only by oral route and the other by oral andintravenous routes. We followed up the animals for five days through clinical manifestations,serum and fecal viral load, hematology and dosage of serum electrolytes. Moreover, weinvestigated the profile of immune cells in peripheral blood, detection of cytokines in theserum, immunofluorescence assays for the detection of rotavirus non-structural protein andimmune cells in the intestine. The absence of diarrhea episodes was considered a good signfor the clinical efficacy of IgY immunotherapy, however, viral RNA was found in the stool ofsome animals. The group treated with IgY orally and intravenously was the one in which wedid not detect viral genome in faeces. As for the cell populations in peripheral blood, it wasnot observed significant difference between groups...